Ftse Mib
36.438,11
-0,77%
DAX
21.413,35
-0,45%
S&P 500
6.037,88
0,72%
NASDAQ
19.654,02
1,35%
Bitcoin
97.848,69
-0,01%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Enovis Corporation (ENOV) Enovis Corporation (ENOV) Notizie

ENOV

Enovis (ENOV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ENOV
DataOraFonteTitoloSimboloCompagnia
29/01/202513:00GlobeNewswire Inc.Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26thNYSE:ENOVEnovis Corporation
28/01/202513:17Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENOVEnovis Corporation
28/01/202512:51Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NYSE:ENOVEnovis Corporation
17/01/202512:00GlobeNewswire Inc.Enovis™ Announces Leadership Change to International Surgical BusinessNYSE:ENOVEnovis Corporation
08/01/202500:19PR Newswire (US)Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600NYSE:ENOVEnovis Corporation
06/01/202522:15GlobeNewswire Inc.Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNYSE:ENOVEnovis Corporation
18/11/202422:10GlobeNewswire Inc.Enovis to Participate in Upcoming Investor ConferencesNYSE:ENOVEnovis Corporation
14/11/202419:28Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:ENOVEnovis Corporation
06/11/202422:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ENOVEnovis Corporation
06/11/202412:00GlobeNewswire Inc.Enovis Announces Third Quarter 2024 ResultsNYSE:ENOVEnovis Corporation
10/10/202413:00GlobeNewswire Inc.Enovis to Host Third Quarter 2024 Results Conference Call on November 6thNYSE:ENOVEnovis Corporation
09/09/202421:50GlobeNewswire Inc.Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling TechnologiesNYSE:ENOVEnovis Corporation
05/09/202414:00GlobeNewswire Inc.Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual MeetingNYSE:ENOVEnovis Corporation
20/08/202414:00GlobeNewswire Inc.Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision ProceduresNYSE:ENOVEnovis Corporation
19/08/202414:00GlobeNewswire Inc.Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched DurabilityNYSE:ENOVEnovis Corporation
08/08/202402:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENOVEnovis Corporation
07/08/202412:00GlobeNewswire Inc.Enovis Announces Second Quarter 2024 ResultsNYSE:ENOVEnovis Corporation
25/07/202412:00GlobeNewswire Inc.Enovis Announces Time Change for Second Quarter 2024 Results Conference CallNYSE:ENOVEnovis Corporation
16/07/202413:00GlobeNewswire Inc.Enovis to Host Second Quarter 2024 Results Conference Call on August 7thNYSE:ENOVEnovis Corporation
12/07/202414:00GlobeNewswire Inc.Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®NYSE:ENOVEnovis Corporation
31/05/202422:05Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:ENOVEnovis Corporation
02/05/202412:00GlobeNewswire Inc.Enovis Announces First Quarter 2024 ResultsNYSE:ENOVEnovis Corporation
17/04/202413:00GlobeNewswire Inc.Enovis to Host First Quarter 2024 Results Conference Call on May 2ndNYSE:ENOVEnovis Corporation
28/03/202412:00GlobeNewswire Inc.Enovis to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNYSE:ENOVEnovis Corporation
22/02/202412:57Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:ENOVEnovis Corporation
22/02/202412:22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ENOVEnovis Corporation
22/02/202412:00GlobeNewswire Inc.Enovis Announces Fourth Quarter and Full Year 2023 ResultsNYSE:ENOVEnovis Corporation
21/02/202422:48Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:ENOVEnovis Corporation
14/02/202416:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ENOVEnovis Corporation
12/02/202417:30GlobeNewswire Inc.Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual MeetingNYSE:ENOVEnovis Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ENOV

La tua Cronologia

BOV
TFCO4
Track & Field PN
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci